Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
 6 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Cash flows from operating activities    
Net loss attributable to common stockholders $ (271,868) $ (129,455)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation, depletion and amortization 30,286 31,768
Loss on early extinguishment of debt 80,510 15,097
Amortization of debt issuance and discount costs 4,943 14,287
Non-cash compensation 176,123 4,248
Non-cash derivative gain (loss), net (77,935) 1,227
Net loss attributable to non-controlling interest (16,664) (5,401)
Use of restricted cash and cash equivalents 55,842 21,978
Crest royalty 0 (25,664)
Other (2,021) (2,861)
Changes in operating assets and liabilities:    
Accounts and interest receivable (23,250) (1,681)
Accounts payable and accrued liabilities 25,173 (19,648)
LNG inventory, net 1,289 4,243
Deferred revenue (1,955) (3,480)
Prepaid expenses and other (2,316) 405
Net cash used in operating activities (21,843) (94,937)
Cash flows from investing activities    
Investment in Cheniere Partners (11,122) (170,253)
LNG terminal and pipeline costs, net (1,271,365) (38,985)
Use of restricted cash and cash equivalents 1,580,268 214,174
Other (8,815) (8,381)
Net cash provided by (used in) investing activities 288,966 (3,445)
Cash flows from financing activities    
Proceeds from Sabine Pass Liquefaction Senior Notes, net 3,012,500 0
Proceeds from CTPL Credit Facility, net 391,978 0
Proceeds from sale of common units by Cheniere Partners 364,795 8,793
Proceeds from 2013 Liquefaction Credit Facility 100,000 0
Proceeds from sale of common stock, net 0 819,686
Investments in restricted cash and cash equivalents (3,520,638) (455,033)
Repurchases and prepayments of debt 0 (571,884)
Debt issuance and deferred financing costs (228,882) (5,530)
Repayments of 2012 Liquefaction Credit Facility (100,000) 0
Distributions to non-controlling interest (30,872) (16,330)
Purchase of treasury shares (71,913) (1,893)
Other 11,119 (702)
Net cash provided by used in financing activities (71,913) (222,893)
Net increase (decrease) in cash and cash equivalents 195,210 (321,275)
Cash and cash equivalents—beginning of period 201,711 459,160
Cash and cash equivalents—end of period $ 396,921 $ 137,885